Purpose: Tumor motion amplitude varies during treatment. The purpose of the study was to evaluate the intra-and interfraction tumor motion and variability in patients with liver cancer treated with fiducial-based real-time tracking stereotactic body radiotherapy (SBRT).
| INTRODUCTION
Radiation-induced liver disease (RILD) has the potential to lead to liver failure, and the risk of RILD is correlated with the mean dose to the liver. 1 With the use of stereotactic body radiation therapy (SBRT) for the treatment of liver tumors, it became feasible to achieve high rates of tumor control while minimizing the irradiation of the surrounding uninvolved liver, thereby reducing the risk of RILD. 2, 3 SBRT needs to precisely deliver a highly conformal dose to the target in fewer fractions. Hence, tumor motion evaluation and its use in treatment planning are important for liver SBRT.
There are several methods for determining liver tumor motion in a simulation process, including four-dimensional computed tomography (4DCT), 4 inhale/exhale breath-hold CT and cine magnetic resonance imaging (MRI). 5 Due to the density difference between a tumor and the surrounding normal tissue, liver tumors are generally only visible in contrast-enhanced CT scans. A synchronized contrast injection method during 4DCT simulation has been reported to account for the problem. 4, 6 However, because intravenous contrast is not routinely used during pretreatment, it is difficult to recognize the tumor in cone beam CT (CBCT) images, and accurate patient alignment becomes a challenge in liver SBRT. Fiducials implanted near the liver tumor have been shown to be effective surrogates and are highly recommended. 2 Bertholet et al. compared four CBCT-based setup strategies for liver tumor. They concluded that marker-based setup was substantially better than bony-anatomy setup. 7 Tumor motion patterns may change during the treatment, with either intra-or interfraction changes. Case et al. investigated intraand interfractional tumor motion variability using CBCT 8 or respiratory-correlated CBCT. 9 However, CBCT or respiratory-correlated CBCT only represents the tumor motion over multiple respiratory cycles during image acquisition. Real-time data from the treatment can provide information with more detail about the tumor motion.
Using real-time data, Malinowski et al. 10 showed that the tumor baseline position can change in most treatment fractions in lung and pancreatic cancer patients.
Understanding tumor motion before and during treatment is important for high-quality SBRT treatments, especially for those in which real-time tumor tracking is not available. For this purpose, we investigated the logfile-based tumor motion amplitude, intra-and interfraction tumor motion variability and baseline shift during the course of treatment. The results might contribute to current knowledge regarding liver tumor motion management.
| MATERIALS AND METHODS

2.A | Patients
In our institution, liver SBRT patients were treated with a robotic CyberKnife (Accuray Incorporated, Sunnyvale, USA) using the Syn- Table 1 .
2.B | Simulation, prescription and treatment planning
All patients were implanted with 2-4 fiducials near the tumor under CT guidance. 11 Simulation was typically administered 7-10 days after the implantation, which can minimize the risk of marker migration. The patients were supine with their arms along their sides and were immobilized with a customized vacuum body mold. Exhalation breath-hold contrast-enhanced planning CT was used for treatment
planning. An additional 4DCT was used to evaluate tumor motion in all patients in case dynamic tracking was not possible during treatment.
The gross target volume (GTV) was expanded by a 5-mm radial and 8-mm craniocaudal margin for the planning target volume (PTV).
The radiation dose was prescribed according to the isodose surface covering the PTV, typically 75% to 85% of the maximum PTV dose. SBRT was planned and delivered using the CyberKnife under free breathing.
2.C | Synchrony respiratory tracking system
The primary concept of the tracking treatment using the Synchrony system is to build a correlation model between the internal tumor location and the external marker position. 12 The internal tumor location was determined using the centroid of fiducials, which were implanted near the tumor before simulation, and the external optical marker was attached to a vest worn by the patient during the treatment. The correlation model is updated with each new X ray acquisition (typically every 60 s), thus accounting for the change of motion pattern during treatment. More detailed information can be found in the reference manual. 13 The accuracy of the correlation model has been evaluated in a previous publication. 14 The mean correlation model errors were less than 0.3 mm in their study, indicating that use of the correlation model to predict the tumor position is reliable. The internal tumor position throughout the treatment was estimated using the correlation model and was stored in log files (Modeler.log).
2.D | Tumor motion analysis
Tumor motion amplitudes, baseline drifts and intra-and interfraction amplitude variability during treatment were evaluated.
Logfile-based tumor motion amplitudes were defined as the range of a 5% cutoff in each of the deepest inhale and exhale positions. To determine the 5% cutoffs, the probability distribution functions (PDFs) of tumor positions were calculated using the data recorded in the logfiles [ Fig. 1(b) ]. The cumulative probability as a function of tumor positions also be calculated: the corresponding positions of 5% (C 5% ) and 95% (C 95% ) cumulative probability were the cutoffs [ Fig. 1(c) ], and the logfile-based amplitude was the range between C 5% -C 95% . This logfile-based amplitude was compared with the amplitudes decided by the 4DCT.
The intrafraction amplitude variability was defined as the standard deviation (SD) of the peak-to-peak distance (the peak-to-peak distance was defined as the distance of each inhale peak to the next exhale peak) during one treatment fraction.
The interfraction amplitude variability was defined as the SD of the logfile-based tumor motion amplitude over the entire treatment course.
Baseline shift was defined as a change in the mean tumor position from the baseline position across 10-min blocks of data, The mean tumor position of the first 5 min after starting the treatment was taken as the baseline tumor position. The incidence of baseline shift exceeding 2 mm and 5 mm were evaluated, based on the consideration of (a) a > 2-mm setup error, which required realignment for those patients treated with conventional LINAC at our institution; and (b) a 5-8 mm GTV to PTV margin. For comparison with the other publication, 15 the incidence of baseline shift exceeding 3 mm was also calculated. Table 2 presents the incidences of baseline shifts exceeding 2 mm, 3 mm and 5 mm in the three time blocks for the SI, LR, AP, and 3D directions. An apparent time trend increase in the incidence of baseline shift can be observed. Interestingly, the incidence of baseline shifts >2 mm in the SI direction for the first fraction was 35.7%, which is larger than the incidences of the 2nd and 3rd fractions, which were 21.4% and 14%, respectively.
| DISCUSSION
The intra-and interfraction amplitudes clearly vary. Recently, realtime observation of tumor movement during treatment is becoming more common, 16, 17 and new apparatuses integrating this function are gradually being used by clinical facilities. 18, 19 CyberKnife is the earliest commercial device for real-time monitoring and tracking.
Logfile data from the Synchrony system record the tumor motion during the treatment, and the amplitudes determined by the logfile data may be closer to reality than 4DCT or CBCT methods. Eccles et al. 20 evaluated the liver tumor motion using cine-MRI, and the scanning time was at least 5 min. The logfile-based amplitudes in this study were consistent with the results reported by the above literature, which showed the amplitudes measured for long periods.
Knybel et al. 15 analyzed the intrafraction amplitude variation in T A B L E 2 Incidence of baseline shifts exceeding 2 mm, 3 mm, and 5 mm for the SI, LR, AP, and 3D directions. 
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